$IDVV Company's CBD Winery Announces First Purchase Order

New Post Public Reply Private Reply Replies (0) Message Board
trooperstocks
338
$IDVV Company's CBD Winery Announces First Purchase Order For CBD Infused Wine
TEMECULA, CA / ACCESSWIRE / February 1, 2019 / International Endeavors Corporation, Inc. (OTC PINK: IDVV) today announced that its subsidiary CBD Winery has received a purchase order for 100 cases of it's CBD infused alcohol free wine.

Terms of the purchase order state that the customer will purchase 100 cases at wholesale with the intention of selling in the state of California. Each case contains 12 bottles and has a Suggested Retail Price of $59.00 per bottle. International Endeavors plans to expand production of CBD Winery in the Temecula Valley Wine Country. CBD Winery is currently seeking additional suppliers of alcohol free wine to meet the demand of its CBD wine product.

The passage of the 2018 Farm Bill has legalized hemp and according to company council has paved the way for CBD infused alcohol free wine beverages. The wine is an alcohol free red wine produced in Temecula Valley and infused with THC free CBD.

Company spokesman Barry Smith stated, "The Company has been formulating a plan to bring CBD to market using alcohol free wine as the delivery vehicle. The company plans to scale operations to keep up with the surging demand for the CBD Winery brand. Currently CBD Winery is able to produce approximately 500 cases per quarter using in house product and will be working with various California wine growers to support excess demand. International Endeavors Corporation is very excited at initial demand of the product. We expect more product to be available in the coming weeks."

With the launch of CBD Winery, International Endeavors Corp (IDVV) has entered spaces being pursued by companies such as Canopy Growth (CGC) and Constellation Brands (STZ). During Constellation's conference call, an analyst asked whether the company or Canopy might handle the potential sale of CBD beverages if the 2018 Farm Bill passed. In response, CEO Rob Sands said: "The answer is both."

Recently, Coca-Cola (KO) stated it was "closely watching" the growth of CBD as an ingredient in wellness-themed drinks. PepsiCo (PEP) said it had "no plans at this point" to pursue CBD drinks but would look "very critically" at the space.

Molson Coors (TAP) in August said its Canadian business would partner with a Canadian cannabis company to test out cannabis-based beverages. Other big alcohol companies claim they're watching the cannabis industry closely.

What is CBD Infused Wine

Cannabidiol (CBD) is one of the most prevalent chemical compounds in the cannabis plant. Unlike the more widely known molecule, tetrahydrocannabinol (THC), CBD is completely non-psychoactive.

Users of CBD do not expect to get "high" off of this organic chemical, however, CBD is all relaxation without intoxication.

While CBD still has an effect on your body, consuming CBD by itself isn't going to send you on the cerebral adventure associated with THC. For decades, medical professionals and the general public overlooked CBD because psychoactive cannabis took center stage.

In more recent times however, the medical potential of CBD has taken cannabis to mainstream audiences. Preclinical trials over the past four decades have found that the cannabinoid shows promise as an:

Anti-inflammatory
Antioxidant
Neuroprotectant
Anxiolytic
Antidepressant
Anti-psychotic
CBD is often used by patients in the form of an oil. Patients with more chronic conditions such as cancer and epilepsy often use medical cannabis oil extracted from high-CBD varieties of cannabis.

When infused in a high quality wine such as the product IEC is bringing to market the experience is one of a kind.

About CBD Winery

CBD Winery is a boutique winery based out of the Temecula Valley Wine Country that focuses on the production of CBD infused wine. For more information including pricing please visit www.cbdwinery.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 4

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 2

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 1

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 3

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 6

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 3

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 6

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 2

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Acumen Pharmaceuticals to Showcase Innovations at Conference

Updated Category News Views 115

Acumen Pharmaceuticals to Present at Health Conference Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a pioneering clinical-stage biopharmaceutical company, is set to engage in a significant fireside chat at the 7th Annual Evercore ISI HealthCONx Conference. This event will happen shortly, providing a platform for Acumen to discuss their innovative approaches to tackling...

Continue Reading
Chanson International Holding Reports Fiscal Year 2025 Mid-Year Results

Updated Category News Views 192

Chanson International Holding Reports Mid-Year Financial Results Chanson International Holding (NASDAQ: CHSN) has recently unveiled its financial performance for the first half of the fiscal year 2025. As a key player in the bakery and beverage sectors, the company's unaudited results signify its resilience in a fluctuating market. Overview of Financial Performance...

Continue Reading
Investors Are Strategically Analyzing REGN Options Activity

Updated Category News Views 66

Examining Recent Changes in REGN Options There's been a noteworthy shift in sentiment among financial experts regarding Regeneron Pharmaceuticals. A recent analysis of the trading patterns in REGN options has revealed a blend of bullish and bearish movements in the market. This information serves as a foundation for understanding the current factors that are shaping...

Continue Reading
Analysts Raise Price Targets for CVS After Strong Earning Report

Updated Category News Views 99

CVS Health Exceeds Expectations with Recent Earnings CVS Health Corp (NYSE: CVS) delivered an impressive earnings report for its fourth quarter, showing robust sales numbers that surpassed analysts' expectations. The company announced fourth-quarter sales totaling an incredible $97.71 billion, outpacing the consensus estimate of $97.19 billion. Adjusted Earnings Report...

Continue Reading
Healthcare Triangle and Teyame AI Join Forces to Innovate Patient Engagement

Updated Category News Views 161

Healthcare Triangle Announces Strategic Partnership with Teyame AI Healthcare Triangle, Inc. (Nasdaq: HCTI) is excited to share its recent agreement with Teyame AI LLC, a visionary corporation aiming to revolutionize customer experience through artificial intelligence. This partnership is a transformative step that will not only enhance HCTI's SaaS capabilities but is...

Continue Reading